Video

OncLive® Institutional Perspectives in Cancer: Lung Cancer – Chaired by Melissa L. Johnson, MD

OncLive® Institutional Perspectives in Cancer: Lung Cancer – Chaired by Melissa L. Johnson, MD

OncLive® Institutional Perspectives in Cancer: Lung Cancer – Chaired by Melissa L. Johnson, MD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers

  • Melissa L Johnson, MD | Sarah Cannon Research Institute at Tennessee Oncology
  • David Spigel, MD | Sarah Cannon Research Institute at Tennessee Oncology
  • Wade Iams, MD, MSCI | Vanderbilt Ingram Cancer Center
  • Andrew McKenzie, PhD | Sarah Cannon Research Institute at Tennessee Oncology
  • Denis M. Gilmore, MD | TriStar Medical Group

Topics

  • Immunotherapy in NSCLC
  • Actionable Targets in NSCLC
  • SCLC Management
  • Personalized Medicine in NSCLC
  • Role of Surgery in Lung Cancer

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Minoo Battiwalla, MD, MS, director, Blood Cancer Outcomes Research, Sarah Cannon Research Institute, TriStar Medical Group
Meredith McKean, MD
Erika P. Hamilton, MD, director, Breast Cancer, director, Gynecologic Cancer Research, Sarah Cannon Research Institute
Minoo Battiwalla, MD
Video 8 - 2 KOLs are featured in, "Emerging Trials in the Management of HR+/HER2- mBC"
Video 7 - 2 KOLs are featured in, "Adverse Event Data and Management for Optimal Quality of Life in HR+/HER2- mBC"
Video 6 - 2 KOLs are featured in, "Other trials of note investigating targeted therapies in later line HR+/HER2- mBC"
Adam M. Brufsky, MD, PhD, and Erika P. Hamilton, MD, experts on breast cancer
Video 4 - 2 KOLs are featured in, "Clinical Decision Making to Overcome Treatment Resistance in 2L HR+ HER2- mBC"
Video 2 - 2 KOLs are featured in, "Mechanisms of Resistance after 1L CDK4/6i + ET: The PI3K/AKT/PTEN Pathway"